# Collegium Pharmaceutical, Inc: Form 8-K, filed Jan 10, 2018

- Company: [Collegium Pharmaceutical, Inc](/companies/coll.md) (CIK 1267565)
- Form: 8-K
- Filed: 2018-01-10
- Accepted by EDGAR: Jan 10, 2018, 09:00 ET
- Period: 2018-01-09
- Accession: 0001104659-18-001560
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1267565/000110465918001560/a18-2498_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1267565/000110465918001560/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1267565/000110465918001560/a18-2498_18k.htm

Filed Jan 10, 2018.
Source: SEC EDGAR, the filing index for accession 0001104659-18-001560. Last ingested by Listed: Nov 10, 2026, 23:07 ET. No prices; not investment advice.
